Clinical Trial Update: Comparison of Insulin Degludec With Insulin Glargine U100 for Adults With Type 1 Diabetes Crossing Multiple Time Zones. [Phase 4]

View source ↗

Summary

Phase 4 trial comparing insulin degludec with insulin glargine U100 in adults with type 1 diabetes across multiple time zones.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 1 Diabetes Mellitus

Drugs mentioned

• insulin degludec (insulin degludec)
• insulin glargine U100 (insulin glargine)

Snippet

Sponsor: Sansum Diabetes Research Institute | Conditions: Diabetes Mellitus, Type 1 | Phase 4 | Status: COMPLETED | Results posted: 2022-06-02